Prioritizing Bodily Exposures: Ingestion, Inhalation, and Dermal Load
Not all exposure pathways contribute equally. This Greenpaper introduces a practical framework for prioritizing ingestion, inhalation, and dermal exposure based on relative biological impact.
What It Is
Not all exposure pathways carry equal biological weight. Substances enter the body primarily through ingestion, inhalation, and dermal absorption. Each route differs in absorption efficiency, systemic distribution, metabolic processing, and elimination.
The digestive tract is designed for uptake, specialized cells, large surface area, and direct access to circulation, so swallowing a substance typically results in higher systemic absorption than brief dermal contact. The lungs are another high-priority pathway: inhalation allows substances to pass rapidly into circulation, and because breathing is involuntary, it can occur without deliberate action. The skin is designed for selective defense; the stratum corneum limits penetration, so dermal absorption is generally slower and more variable. But “less than ingestion” does not mean “negligible.” Certain compounds are formulated for penetration; others are small, lipophilic, or applied repeatedly under conditions that enhance absorption, heat, occlusion, shaving, friction, or compromised barrier integrity. Leave-on products such as lotions, deodorants, sunscreen, and fragrance can remain in contact for hours daily, resembling chronic low-dose exposure. Prioritizing bodily exposures means recognizing that route, frequency, and duration shape systemic impact. It is an allocation decision.
Why We Care
Risk perception often treats all exposures as equal or reacts to whichever is most visible. Neither is structurally sound. A practical hierarchy looks like this:
- ▪Ingestion: Typically higher absorption and higher systemic priority.
- ▪Inhalation: Rapid pulmonary absorption and high priority.
- ▪Dermal (leave-on, repeated use): Moderate but patterned exposure with cumulative relevance.
- ▪Dermal (rinse-off, infrequent): Lower relative systemic concern.
This hierarchy does not eliminate concern about personal care products; it contextualizes it. Mitigation urgency should reflect frequency of use, surface area covered, duration of contact, population vulnerability (pregnancy, infancy, endocrine disorders, compromised health), and the strength of evidence for systemic effects. The goal is not to treat shampoo as equivalent to drinking a solvent, but to recognize that daily dermal exposure over decades is biologically different from a rare, short contact event.
What We Do
Prioritizing bodily exposures requires a structured sequence rather than scattered swaps.
- ▪Address high-absorption routes first: Evaluate ingestion and inhalation before low-contact dermal sources. Drinking water quality, food packaging under heat, and indoor air often deserve earlier scrutiny than occasional topical contact.
- ▪Distinguish leave-on from rinse-off: Leave-on formulations used daily across large surface areas carry greater cumulative relevance than products quickly rinsed.
- ▪Evaluate repetition and redundancy: Consolidating overlapping products reduces patterned exposure more effectively than chasing minor ingredient substitutions.
- ▪Incorporate vulnerability windows: Pregnancy, infancy, hormonal transitions, autoimmune conditions, and compromised detoxification may justify stricter thresholds.
- ▪Avoid false equivalence: Treating all exposures as equally urgent produces cognitive overload and misallocated effort.
The purpose of this hierarchy is not to minimize dermal exposure, but to sequence action logically. When route, frequency, and duration are evaluated systematically, mitigation becomes proportionate, and proportionate mitigation is sustainable.
Further Exploration
For readers interested in the biological distinctions between exposure routes and systemic absorption:
Human Health Risk Assessment: Exposure Assessment, U.S. EPA.
Percutaneous absorption mechanisms and influencing factors, Lademann, J., et al. Dermatology (2004).
Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals, WHO Environmental Health Criteria Series.
References
U.S. Environmental Protection Agency. Human Health Risk Assessment: Exposure Assessment.
Lademann, J., Schaefer, H., Otberg, N., et al. Percutaneous absorption mechanisms and influencing factors. Dermatology (2004).
World Health Organization. Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals.
Turn insight into action
Ready to apply this to your own home?
Get the prioritized, room-by-room system in The Low-Tox Home Blueprint, or work with us directly.
